Screener
Recursion Pharmaceuticals, Inc. RXRX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
FAQ
- What is Recursion Pharmaceuticals, Inc.'s current ratio?
- Recursion Pharmaceuticals, Inc. (RXRX) reported current ratio of 5× in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s current ratio increased by 40.6% year-over-year, from 3.6× to 5×.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s current ratio has grown at a -13.8% compound annual growth rate (CAGR), from 11.5× to 5.5×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Recursion Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude